Literature DB >> 23177062

Evaluating patients undergoing colorectal surgery to estimate and minimize morbidity and mortality.

Samantha K Hendren1, Arden M Morris.   

Abstract

This review discusses the preoperative evaluation of patients preparing for elective colorectal resection, touching on several specific categories of morbidity, including cardiac, pulmonary, hepatic, renal, and surgical site complications. For each of these, the evidence for practices that optimize patient function and minimize risk is reviewed. Finally, authors discuss how to counsel high-risk surgical patients, including those for whom elective surgery is not recommended.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23177062     DOI: 10.1016/j.suc.2012.09.005

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Improving quality of surgical care and outcomes: factors impacting surgical site infection after colorectal resection.

Authors:  Virginia Oliva Shaffer; Caitlin D Baptiste; Yuan Liu; Jahnavi K Srinivasan; John R Galloway; Patrick S Sullivan; Charles A Staley; John F Sweeney; Joe Sharma; Theresa W Gillespie
Journal:  Am Surg       Date:  2014-08       Impact factor: 0.688

2.  The impact of retractor SPONGE-assisted laparoscopic surgery on duration of hospital stay and postoperative complications in patients with colorectal cancer (SPONGE trial): study protocol for a randomized controlled trial.

Authors:  Alice M Couwenberg; Maarten J P Burbach; Anke B Smits; Marco Van Vulpen; Wilhemina M U Van Grevenstein; Peter G Noordzij; Helena M Verkooijen
Journal:  Trials       Date:  2016-03-10       Impact factor: 2.279

3.  An RCT to Increase Breast and Colorectal Cancer Screening.

Authors:  Victoria L Champion; Shannon M Christy; William Rakowski; David R Lairson; Patrick O Monahan; Wambui G Gathirua-Mwangi; Timothy E Stump; Erika B Biederman; Carla D Kettler; Susan M Rawl
Journal:  Am J Prev Med       Date:  2020-08       Impact factor: 5.043

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.